Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.25% vs -2.60% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -34.20% vs 64.38% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -50.00% vs 29.97% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 23.40% vs -18.97% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Guizhou Xinbang Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.25% vs -2.60% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -6.42% vs -3.06% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -34.20% vs 64.38% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -28.29% vs -27.28% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -50.00% vs 29.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -51.26% vs -21.03% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 23.40% vs -18.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -3.33% vs -44.44% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






